Literature DB >> 22903755

Anti-allergic effects of So-Cheong-Ryong-Tang, a traditional Korean herbal medicine, in an allergic rhinitis mouse model.

Ji-Hun Mo1, Seung-Eun Lee, Jee Hye Wee, Ji-Eun Lee, Chae-Seo Rhee, Chul Hee Lee, Dong-Young Kim.   

Abstract

The herbal medicine, So-Cheong-Ryong-Tang (SCRT) has been empirically used for the treatment of allergic rhinitis for hundreds of years; however, its in vivo effects on allergic rhinitis have been rarely elucidated. We aimed to evaluate the anti-allergic effects of SCRT in an allergic rhinitis mouse model and to examine the underlying mechanism(s) of its anti-allergic effects. BALB/c mice were sensitized with ovalbumin (OVA) and alum and then challenged intranasally with OVA. SCRT (1 g/kg) was given to the treatment group, and multiple parameters of allergic responses were evaluated to determine the effects of SCRT on allergic rhinitis. SCRT reduced allergic symptoms, such as rubbing and sneezing, and eosinophil infiltration into the nasal mucosa. It also suppressed serum total IgE, OVA-specific IgE, and OVA-specific IgG1 levels and increased OVA-specific IgG2a level. SCRT significantly reduced expression of the Th2 cytokine, IL-4; however, the expression of IL-5, IFN-γ, and IL-10 was unchanged in the nasal mucosa of the treatment group (by real-time RT-PCR). In splenocyte culture, levels of both IL-4 and IL-5 decreased, and IFN-γ level increased in the treatment group; however, levels of IL-10 and TGF-β were unaffected by administration of SCRT. This study shows that SCRT induced anti-allergic effects by decreasing, locally and systemically, the Th2 cytokine IL-4, isotype switching to IgE, and eosinophilic infiltration into the nasal mucosa in an allergic rhinitis mouse model. Thus, SCRT might be considered a potential therapeutic agent in treating allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903755     DOI: 10.1007/s00405-012-2152-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  Modulation of human basophil growth in vitro by xiao-qing-long-tang (syo-seiryu-to), chai-pu-tang (saiboku-to), qing-fei-tang (seihai-to), baicalein and ketotifen.

Authors:  Y Tanno; Y Shindoh; T Takishima
Journal:  Am J Chin Med       Date:  1989       Impact factor: 4.667

2.  The effect of Chinese herbal medicine, xiao-qing-long tang (XQLT), on allergen-induced bronchial inflammation in mite-sensitized mice.

Authors:  S T Kao; S D Wang; J Y Wang; C K Yu; H Y Lei
Journal:  Allergy       Date:  2000-12       Impact factor: 13.146

3.  Asiasari radix inhibits immunoglobulin E production on experimental models in vitro and in vivo.

Authors:  H M Kim; Y S Moon
Journal:  Immunopharmacol Immunotoxicol       Date:  1999-08       Impact factor: 2.730

4.  Glycyrrhizin alleviates experimental allergic asthma in mice.

Authors:  Arjun Ram; U Mabalirajan; Moumita Das; Indranil Bhattacharya; Amit K Dinda; Sharad V Gangal; Balaram Ghosh
Journal:  Int Immunopharmacol       Date:  2006-06-06       Impact factor: 4.932

5.  Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats.

Authors:  Asish Kumar Das; Hiroyuki Mizuguchi; Madoka Kodama; Shrabanti Dev; Hayato Umehara; Yoshiaki Kitamura; Chiyo Matsushita; Noriaki Takeda; Hiroyuki Fukui
Journal:  Allergol Int       Date:  2008-12-01       Impact factor: 5.836

Review 6.  Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.

Authors:  Ming O Li; Richard A Flavell
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

7.  Antigen-specific versus total immunoglobulin synthesis: total IgE and IgG1, but not IgG2a levels predict murine antigen-specific responses.

Authors:  Ian P Lewkowich; Julia D Rempel; Kent T HayGlass
Journal:  Int Arch Allergy Immunol       Date:  2004-01-26       Impact factor: 2.749

8.  Pinellic acid from the tuber of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine.

Authors:  Takayuki Nagai; Hiroaki Kiyohara; Kaori Munakata; Tatsuya Shirahata; Toshiaki Sunazuka; Yoshihiro Harigaya; Haruki Yamada
Journal:  Int Immunopharmacol       Date:  2002-07       Impact factor: 4.932

9.  Evaluation of the immunity activity of glycyrrhizin in AR mice.

Authors:  Xiao-Lan Li; Ai-Guo Zhou
Journal:  Molecules       Date:  2012-01-12       Impact factor: 4.411

10.  Regulation of transcription of immunoglobulin germ-line gamma 1 RNA: analysis of the promoter/enhancer.

Authors:  M Z Xu; J Stavnezer
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more
  4 in total

1.  Characterization of a novel high-dose ovalbumin-induced murine model of allergic sinonasal inflammation.

Authors:  Michelle Mendiola; Anuj Tharakan; Mengfei Chen; Tomefa Asempa; Andrew P Lane; Murugappan Ramanathan
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-05       Impact factor: 3.858

2.  Dynamic Microbial Shifts and Signatures of Long-Term Remission in Allergic Rhinitis After an Herbal Formula Treatment.

Authors:  Libing Zhu; Yuning Wu; Chenglong Lin; Lin Tang; Bin Yu; Wenrong Wan; Jingxiu Xuan; Yanling Du; Zhangran Chen; Wei Liang
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

3.  Evaluation of shoseiryuto for seasonal allergic rhinitis, using an environmental challenge chamber.

Authors:  Junya Kurita; Syuji Yonekura; Tomohisa Iinuma; Riyo Yoneda; Sakiko Imamoto; Toyoyuki Hanazawa; Yohei Kawasaki; Takao Namiki; Yoshitaka Okamoto
Journal:  World Allergy Organ J       Date:  2022-03-20       Impact factor: 4.084

4.  Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial.

Authors:  Min-Hee Kim; Youme Ko; Jin-Hyang Ahn; Younghee Yun; Mi-Na Yun; Seong-Gyu Ko; Inhwa Choi
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.